Amundi MSCI China A UCITS ETF Acc
| Issuer: Amundi ETF |
| Asset Class: Equity |
| TER: 35bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 09 Sep 2014 |
| Ticker: CNAA |
| ISIN: FR0011720911 |
This product provides targeted exposure to China's domestic equity market, specifically A-shares, which are stocks of mainland Chinese companies trading on the Shanghai and Shenzhen stock exchanges. Historically, accessing this market has been complex for international investors, but this fund offers a direct and regulated route. It is designed for investors looking to participate in the growth story of the world's second-largest economy, capturing the performance of its large and mid-capitalization companies. The A-share market is vast and diverse, offering a different set of opportunities compared to Chinese companies listed offshore, such as H-shares or ADRs.
Investing in this fund allows for diversification away from more developed markets and provides a purer play on the Chinese domestic economy, which is increasingly driven by consumption and technological innovation. The underlying index includes key players across various sectors, from financials and industrials to consumer staples and healthcare. However, investors should be mindful of the specific risks associated with this market, including potential regulatory changes, geopolitical tensions, and currency fluctuations, as the underlying assets are denominated in Chinese Yuan. The A-share market can also exhibit higher volatility compared to developed markets.
This instrument is suitable for investors with a long-term horizon and a higher risk tolerance who believe in the continued economic expansion and market maturation of China. By physically replicating the index, the fund holds the actual shares of the constituent companies, offering transparency. The accumulating share class structure is efficient for long-term compounding as all dividends are automatically reinvested. It can serve as a core holding for a dedicated emerging markets allocation or as a satellite position to enhance a global equity portfolio with specific exposure to mainland China's dynamic corporate landscape.